LBI-HTA - Publications - Search - [Herceptin®/Trastuzumab for metastatic breast cancer]

Wild, C. (2005): [Herceptin®/Trastuzumab for metastatic breast cancer]. HTA-Newsletter 40: 3.

[img]
Preview
PDF (HTA-Newsletter 40) - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
124Kb

Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes


Item Type:HTA Newsletter Item
Keywords:Herceptin, trastuzumab, monoclonal antibody, breast cancer, mammary carcinoma, first-line treatment, combination therapy, paclitaxel, anthracycline, effectiveness, costs
Subjects:WP Gynaecology > WP 800-910 Breast
WA Public health > WA 300-395 Health problems of special population groups > WA 309 Women´s health
QW Microbiology. Immunology
Related URLs:
References:1. NHSC/GB 2005: Trastuzumab (Herceptin) for breast cancer – adjuvant early disease. URL: http://pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/
2005reports/trastuzumab.pdf.

2. HAYES/USA 2004: Trastuzumab (Herceptin(R)) for breast cancer.

3. NCCHTA/GB 2002: The clinical effectiveness of trastuzumab for breast cancer: a systematic review. URL: http://www.ncchta.org/execsumm/summ613.htm.

4. EMEA 2000: Trastuzumab. URL: http://www.emea.eu.int/humandocs/PDFs/EPAR/
Herceptin/177400de1.pdf.
Language:German
Number:40
Deposited on:25 Feb 2008 18:41
Last Modified:25 Feb 2008 20:31

Repository Staff Only: item control page